What detailed metabolomic analysis would say happens when you take omega-3? -354 downstream FAs and oxylipins shift significantly. -37 of the 354 (including EPA but not DHA levels) have significant associations with cardiovascular outcomes. Learn more at aha.apprisor.org/index.cfm?k…

- In #VITAL trial, Lp(a)-C was NOT a/w increased CVD risk - #Omega3 (1g/day EPA DHA) vs placebo did NOT reduce Lp(a)-C levels (small increase of 4.2%) Check out Dr. Zareen Farukhi’s oral abstract (Control No. 16471) #AHA20 @BrighamResearch @BWHDPM #cardiotwitter

Who would have thought that 1g of omega-3 a day leads to such profound changes in bioactive lipids and conventional downstream inflammatory and lipid biomarkers. We are continuing our work to get a more detailed picture of what it means for our health.

A pleasure working with @HarvardPhysics Dries Sels, Eugene Demler @odemler @Hesam_Dashti on NMR application for quantum computers! Harvard researchers create hybrid algorithm for NMR readings news.harvard.edu/gazette/sto… via @Harvard #AI

HDL anti-inflammatory function: nonlinear relation with CV events in JUPITER Trial – having more HDL particles was protective only when HD was anti-inflammatory @JAHA_AHA #AHAJournals Proud of your dedication & hard work @remiajalaMD #FIT @Odemler ahajournals.org/doi/full/10.…

#bioc2020 poster "WiNN: Drift correction by white noise normalization for metabolomic studies" f1000research.com/posters/9-…